Get started

TXG

Best stock to buy nowBest stock to buy now - 23.05.2023 10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.
NASDAQ:TXGLong
by firdavs_invest
1
10x Genomics (NASDAQ: $TXG) Looks Ready For Growth! 🍄10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
NASDAQ:TXGLong
by RedHotStocks
2
TXG, Aroon Indicator entered an Uptrend on Oct 19, 2020.Over the last three days, Tickeron A.I.dvisor has detected that TXG's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red line stays below 30, this is an indicator that the stock could be poised for a strong Uptrend. For traders, this could mean going long the stock or exploring call options in the next month. Tickeron A.I.dvisor backtested this indicator and found 92 similar cases, 86 of which were successful. Based on this data, the odds of success are 90%. Current price $152.96 is above $113.51 the highest resistance line found by Tickeron A.I. Throughout the month of 09/17/20 - 10/19/20, the price experienced a +36% Uptrend. During the week of 10/12/20 - 10/19/20, the stock enjoyed a +4% Uptrend growth. Bullish Trend Analysis The Momentum Indicator moved above the 0 level on September 28, 2020. You may want to consider a long position or call options on TXG as a result. Tickeron A.I. detected that in 14 of 16 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 88%. The Moving Average Convergence Divergence (MACD) for TXG just turned positive on October 02, 2020. Looking at past instances where TXG's MACD turned positive, the stock continued to rise, Tickeron A.I. shows that in 6 of 7 cases over the following month. The odds of a continued upward trend are 86%. The Aroon Indicator entered an Uptrend today. Tickeron A.I. detected that in 86 of 92 cases where TXG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.
NASDAQ:TXGLong
by AlTorress